Vectura Group PLC | Cash Flow

Fiscal year is January-December. All values GBP Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
11,600.00
6,200.00
7,000.00
44,500.00
96,200.00
88,200
Depreciation, Depletion & Amortization
7,300.00
8,000.00
22,100.00
67,400.00
106,700.00
91,300
Other Funds
-
-
-
-
1,800.00
45,200
Funds from Operations
2,300.00
7,600.00
22,000.00
33,100.00
21,400.00
27,000
Changes in Working Capital
4,500.00
7,900.00
13,600.00
5,100.00
4,400.00
3,300
Net Operating Cash Flow
2,200.00
300.00
8,400.00
28,000.00
25,800.00
30,300
Capital Expenditures
4,000.00
2,300.00
1,400.00
2,600.00
9,500.00
Sale of Fixed Assets & Businesses
200.00
-
-
2,900.00
-
Purchase/Sale of Investments
-
1,200.00
-
-
-
Net Investing Cash Flow
3,800.00
41,400.00
1,900.00
38,100.00
9,500.00
Issuance/Reduction of Debt, Net
-
-
-
200.00
-
Net Financing Cash Flow
600.00
53,300.00
1,800.00
100.00
2,900.00
Net Change in Cash
5,400.00
11,600.00
8,300.00
7,300.00
11,200.00
Free Cash Flow
6,200.00
2,600.00
7,000.00
25,400.00
16,300.00
Net Assets from Acquisitions
-
37,800.00
500.00
25,000.00
-
Change in Capital Stock
600.00
53,300.00
1,800.00
300.00
900.00
Exchange Rate Effect
-
-
-
2,700.00
2,200.00
Other Uses
-
2,500.00
-
13,400.00
-

About Vectura Group

View Profile
Address
1 Prospect West
Chippenham Wiltshire SN14 6FH
United Kingdom
Employees -
Website http://vectura.com
Updated 07/08/2019
Vectura Group Plc engages in the provision of pharmaceutical development. Its activities include research, development, and commercialization of novel therapeutic products. It operates through the following segments: Switzerland, United Kingdom, Germany, United States of America, and France.